5-Chloro-2-picolinic acid → HCID 86660408, compound
Reaction equation
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]([F:19])=[C:6]([C@:8]2([CH3:18])[CH2:14][C:13]([CH3:16])([CH3:15])[O:12][CH2:11][C:10](=[S:17])[NH:9]2)[CH:7]=1.[Cl:20][C:21]1[CH:22]=[CH:23][C:24]([C:27](O)=[O:28])=[N:25][CH:26]=1>>[F:19][C:5]1[CH:4]=[CH:3][C:2]([NH:1][C:27]([C:24]2[CH:23]=[CH:22][C:21]([Cl:20])=[CH:26][N:25]=2)=[O:28])=[CH:7][C:6]=1[C@:8]1([CH3:18])[CH2:14][C:13]([CH3:16])([CH3:15])[O:12][CH2:11][C:10](=[S:17])[NH:9]1Participants
3
Procedure
The compound was prepared in an analogous manner as described for intermediate B14A from (S)-5-(5-amino-2-fluoro-phenyl)-5,7,7-trimethyl-[1,4]oxazepane-3-thione (intermediate A17A) (132 mg, 0.47 mmol) and commercially available 5-chloro-pyridine-2-carboxylic acid [CAS No. 86873-60-1] (92 mg, 0.58 mmol). The compound was obtained as white foam (177 mg, 72%). MS (ISP): m/z=422.1 [(M+H)+] and 424.1 [(M+2+H)+].
Workup
- customThe compound was prepared in an analogous manner
Sources & evidence
- ORD record
- ord-ab2ca184404242b79ea997f6d586327a
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08673894B2
Reaction notes
Loading…